Test License [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2018-10-07 21:04 (882 d 05:29 ago) – Posting: # 19414
Views: 1,448

Dear RK,

» I applied Test license for some X drug in India, I got permission and I imported the drug (reference) from outside India then conducted one study (pilot). Now I want to conduct one more study (pivotal) with remaining quantity of Reference drug from first study. Here I have some doubts:

» 1) Can I use remaining quantity of reference drug for pivotal
No, You can't use the rest of the reference drug for conducting a BE Study with a new ordered reference drug batch, as they are two different Batches ( Biobatches).

» 2) If we use remaining IPs, Is we need to get Test license permission for pivotal.

Yes, you will need.




Complete thread:

 Admin contact
21,371 posts in 4,463 threads, 1,496 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Monday 01:34 CET (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz